IAPP and Hyperglycemia: Furthermore, since T2D is characterized by oxidative stress, which is exacerbated by both hyperglycemia and amyloid-induced toxicity [3], antioxidant agents may complement strategies aimed at inhibiting α-amylase and α-glucosidase or preventing IAPP aggregation.